Effects of ketoconazole on the pharmacokinetics of lenvatinib (E7080) in healthy participants

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|4|2|155-160

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.2, 2015-03, pp. : 155-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2749-2756

Blackwell Publishing

Access to resources Recommend Favorite

Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 295-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 3, 2015-03 ,pp. : 226-236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 137-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of food on the pharmacokinetics of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, and assessment of dose proportionality in healthy participants

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 279-286

John Wiley & Sons Inc

Access to resources Recommend Favorite